Systemic lupus erythematosus in the setting of HIV-1 infection: a longitudinal analysis
Autor: | Gloria Salazar, John D. Reveille, Binh Y Nguyen, Francis M Williams, Benjamin S. Naovarat |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male medicine.medical_specialty Human immunodeficiency virus (HIV) HIV Infections medicine.disease_cause White People 03 medical and health sciences 0302 clinical medicine Rheumatology Rheumatology clinic immune system diseases Internal medicine Ambulatory Care Prevalence Medicine Outpatient clinic Humans Lupus Erythematosus Systemic 030212 general & internal medicine Longitudinal Studies skin and connective tissue diseases 030203 arthritis & rheumatology African american Systemic lupus erythematosus business.industry virus diseases General Medicine DNA Middle Aged medicine.disease Black or African American Concomitant Antibodies Antinuclear Cohort HIV-1 Female business Male to female |
Zdroj: | Clinical rheumatology. 39(2) |
ISSN: | 1434-9949 |
Popis: | Patients with concomitant HIV-1 infection and systemic lupus erythematosus (SLE) followed longitudinally at an HIV outpatient clinic from 1994 to 2019 were examined. Patients met 1982 and 1997 ACR classification criteria for SLE at the Thomas Street clinic from 1994 to 2019. Clinical and demographic comparisons were made with a non HIV-SLE patient cohort, the Lupus in Minorities Studies, Nature versus Nurture (LUMINA) study. Twenty-two patients with concomitant HIV-1 infection and SLE were identified, including 18 females, 3 males, and 1 male to female transgender. Overall, 81.8% of SLE-HIV patients were African-American compared to 55.3% of the 5856 patients seen at the HIV clinic from 2016 to 2017 (p = 0.02, OR = 3.6). There were 12 patients that developed HIV-1 in the setting of SLE and 10 patients that developed SLE in the setting HIV-1. This demographic distribution was significant when compared with the 1604 unique patients in the HIV rheumatology clinic from 1994 to 2019 (p = 0.03, OR = 5.9) and also significant when compared with the 5856 patients attending the county HIV clinic overall in 2016-2017 (p = 0.008, OR = 7.2). When comparing with the non-HIV SLE cohort, anti-dsDNA antibodies were noted less frequently in all HIV-SLE patients (p = 0.0002) including all sub-cohorts of our patients. Skin/mucosal involvement (p = 0.0003) and cytopenias (p = 0.0001) occurred less frequently in the patients that were diagnosed with HIV after their SLE diagnosis compared to non-HIV SLE patients. In a large county HIV clinic setting, the prevalence of SLE was significantly higher in African American women. Anti-dsDNA antibodies were less frequent in HIV-1 positive SLE patients.Key Points• This paper presents clinical and laboratory data on the largest cohort of SLE patients with HIV-1 infection reported to date.• The prevalence of SLE in a large outpatient HIV-1 clinic was larger than reported in HIV negative population studies.• The prevalence of SLE was particularly high in black HIV-1 infected women.• Skin/mucosal involvement and anti-ds DNA antibodies were less common in patients with HIV-1 and SLE compared to patients with SLE without SLE. |
Databáze: | OpenAIRE |
Externí odkaz: |